验证数据展示
经过测试的应用
Positive FC detected in | bEnd.3 cells |
推荐稀释比
应用 | 推荐稀释比 |
---|---|
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
产品信息
CL488-65214 targets PLVAP in FC applications and shows reactivity with Mouse samples.
经测试应用 | FC Application Description |
经测试反应性 | Mouse |
免疫原 | Mouse lymph node stromal cells 种属同源性预测 |
宿主/亚型 | Rat / IgG2a, kappa |
抗体类别 | Monoclonal |
产品类型 | Antibody |
全称 | plasmalemma vesicle associated protein |
别名 | MECA-32, Plvap, PV 1 |
GenBank蛋白编号 | BC013517 |
基因名称 | Plvap |
Gene ID (NCBI) | 84094 |
RRID | AB_3084167 |
偶联类型 | CoraLite® Plus 488 Fluorescent Dye |
最大激发/发射波长 | 493 nm / 522 nm |
形式 | Liquid |
纯化方式 | Protein A purification |
UNIPROT ID | Q91VC4 |
储存缓冲液 | PBS with 0.09% sodium azide , pH 7.3 |
储存条件 | Store at 2-8°C. Avoid exposure to light. Stable for one year after shipment. |
背景介绍
Plasmalemma vesicle-associated protein (PLVAP), also known as PV-1, PAL-E and MECA-32 antigen, is an endothelial cell-specific type II membrane N-glycosylated glycoprotein with a molecular weight of approximately 50-65 kDa, that forms homodimers in situ (PMID: 7626790; 30231925). The MECA-32 antibody, derived from rats immunized with murine lymph node stroma, shows high specificity for mouse endothelium in both embryonic and mature tissues (PMID: 2683264; 7626790). It recognizes most endothelial cells in the embryonic and in the adult mouse, with the exception of the brain, skeletal, and cardiac muscle, where the MECA-32 antigen has a more restricted distribution. In skeletal and cardiac muscle only small arterioles and venules express the MECA-32 antigen, while in the brain its expression is negatively correlated with the differentiation of the vasculature to form the blood brain barrier (PMID: 7626790).
实验方案
Product Specific Protocols | |
---|---|
FC protocol for CL Plus 488 PLVAP antibody CL488-65214 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |